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Copyright © 200? JCBN Summary The present study investigated the effect of folic acid supplementation on the
Notch signaling pathway and cell proliferation in rat embryonic neural stem cells (NSCs).
The NSCs were isolated from E14–16 rat brain and grown as neurospheres in serum-free
suspension culture. Individual cultures were assigned to one of 3 treatment groups that
differed according to the concentration of folic acid in the medium: Control (baseline folic
acid concentration of 4 mg/l), low folic acid supplementation (4 mg/l above baseline, Folate-L)
and high folic acid supplementation (40 mg/l above baseline, Folate-H). NSCs were identified
by their expression of immunoreactive nestin and proliferating cells by incorporation of
5'bromo-2'deoxyuridine. Cell proliferation was also assessed by methyl thiazolyl tetrazolium
assay. Notch signaling was analyzed by real-time PCR and western blot analyses of the
expression of Notch1 and hairy and enhancer of split 5 (Hes5). Supplementation of NSCs with
folic acid increased the mRNA and protein expression levels of Notch1 and Hes5. Folic acid
supplementation also stimulated NSC proliferation dose-dependently. Embryonic NSCs
respond to folic acid supplementation with increased Notch signaling and cell proliferation.
This mechanism may mediate the effects of folic acid supplementation on neurogenesis in the
embryonic nervous system.
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Introduction
Neural stem cells (NSCs) are highly proliferative cells
that can generate new NSCs and differentiated progeny such
as neurons and glia [1]. Embryonic NSCs consequently play
a major role in neurogenesis and gliogenesis in the develop-
ment of the central nervous system (CNS). Additionally,
NSCs are useful for cell replacement therapy of neuro-
degenerative diseases. For many clinical applications of cell
replacement therapy in the CNS, the NSCs will likely need
to be acquired from embryonic or fetal tissues and then
expanded [2].
Nutrients, such as folate species, influence the prolifera-
tion and differentiation of NSCs. Folate deficiency or
methotrexate inhibition of folate metabolism impairs cell
proliferation in cultures of embryonic NSCs [3], whereas
folic acid supplementation stimulates these cells to pro-
liferate [4]. Cerebral folate deficiency is associated with
developmental delay and lifelong neurological conditions
[5–7]. The CNS pathologies associated with folate defi-
ciency include malformations that develop during embryo-
genesis (neural tube defects) as well as neurological dis-
orders that appear later, such as seizures, dementia and
depression [8–11]. Dietary supplements containing folic
acid, which can be metabolized to biologically active folateFolic Acid and Neural Stem Cell Proliferation
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species, are therefore recommended for prevention of folate
deficiency in women who are or may become pregnant.
There is evidence from studies of various cell types that
some effects of folate deficiency and folic acid supple-
mentation may be mediated by altered levels of substrates
(purines, thymidine, methionine and homocysteine) that
change intracellular signaling pathways [3,  4,  12]. The
identity of the intracellular signaling pathway through
which folic acid influences the fate of embryonic NSCs is
unknown. However, a possible candidate is the Notch
signaling pathway, including Notch1 and its downstream
effector hairy and enhancer of split 5 (Hes5), because this
pathway is an important regulator of CNS growth and
differentiation [13, 14].
NSCs can be isolated from rodent brains and selectively
expanded in chemically defined media, giving rise to
floating spheroid cell aggregates called neurospheres. In the
present study, embryonic rat neurosphere cultures were
used to investigate the effect of folic acid supplementation
on the Notch signaling pathway and cell proliferation in rat
embryonic NSCs.
Materials and Methods
Cell culture
Pregnant Sprague-Dawley rats were purchased from
Beijing Medical Laboratory Animal Co. Ltd. (Beijing,
China). Folic acid, Iscove’s Modified Dulbecco’s Medium
(IMDM), B27 supplement, basic fibroblast growth factor,
epidermal growth factor, dimethyl sulphoxide and 5'-
bromo-2' deoxyuridine (BrdU) were obtained from Gibco
(Carlsbad, CA). Monoclonal antibodies against BrdU,
nestin, Notch1, Hes5 and β-actin were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). All fluorescent
secondary antibodies were obtained from Zhongshan
Goldbridge Biotechnology (Beijing, China). Trizol and
Platinum SYBR Green qPCR Supermix-UDG Kit were
purchased from Invitrogen (Carlsbad, CA).
The experimental procedures were approved by the
Tianjin Medical University Committee on Animal Care.
E14–E16 rat brain cortices were dissected from timed-
pregnant Sprague-Dawley rats and washed 3 times with
culture medium (IMDM, containing 4 mg/l folic acid). The
tissue was cut into small pieces and then dissociated by incu-
bation with 0.25% parenzyme and 0.02% ethylenediamine-
tetraacetic acid (EDTA). This step was followed by agita-
tion, centrifugation and resuspension of the cells in IMDM
that was supplemented with 2% B27 supplement, 20 ng/ml
epidermal growth factor, 20 ng/ml basic fibroblast growth
factor, 2 mmol/l L-glutamine, 100 U/ml penicillin and
phytomycin. The resulting cell suspension was grown at
37°C in a humidified atmosphere containing 95% air, 5%
CO2. The culture medium was replaced every 2 days.
Beginning on day 1 in vitro, individual cultures were
assigned to one of 3 treatment groups that differed according
to the concentration of folic acid in the medium: Control
(baseline folic acid concentration of 4 mg/l), low folic
acid supplementation (4 mg/l above baseline, Folate-L) and
high folic acid supplementation (40 mg/l above baseline,
Folate-H). Thus the final concentrations of folic acid were
8 mg/l and 44 mg/l in Folate-L and Folate-H, respectively.
Immunofluorescence analysis
Briefly, neurospheres on the sixth day in culture were
incubated with the proliferation marker BrdU (10 μg/ml) for
24 h. Then they were stained for BrdU and the NSC marker
nestin. To detect BrdU, the primary antibody was mouse
anti-BrdU monoclonal antibody and the second antibody
was fluorescein isothiocyanate (FITC) conjugated goat anti-
mouse IgG. To detect nestin, the primary antibody was rabbit
anti-nestin monoclonal antibody and the secondary antibody
was tetramethylrhodamine isothiocyanate (TRITC) conju-
gated goat anti-rabbit IgG. Immunoreactive cells were
visualized by fluorescence microscopy. The percentages of
double-positive cells of all cells were calculated.
Methyl thiazolyl tetrazolium (MTT) assay
After 2 days exposure of the neurospheres to the Control,
Folate-L and Folate-H treatments, cell proliferation was
quantified by measuring the time-dependent increase in the
abundance of viable cells. Aliquots containing 5 × 105 cells
were transferred individual wells in a 96-well plate and
then incubated at 37°C for the indicated periods. MTT
(0.5 mg) was added to each well at 4 h before the end of
the incubation period, when the MTT reaction was stopped
by addition of 10% sodium dodecyl sulfate (SDS)-0.1 mol/l
HCl. The cell’s formazan crystals were dissolved in
dimethyl sulphoxide and then absorbance at 490 nm was
measured.
Real-time PCR
Cells were harvested after 6 days of folic acid (or Control)
treatment. Then quantitation of gene expression was done
with the real-time PCR procedure. First-strand cDNA was
synthesized from 2 μg total RNA using M-MLV reverse
transcriptase according to the instructions of the manufac-
turer. The 25 μl of reaction volume was incubated for 60 min
at 42°C, 10 min at 70°C and then held at −20°C. Real-time
PCR was performed using a Platinum SYBR Green qPCR
Supermix-UDG Kit. The 20 μl of PCR mixture included
10.0 μl of PCR MIX, 6.0 μl of cDNA, 0.5 μl of amplifica-
tion primer I, 0.5 μl of amplification primer II and 3.0 μl of
autoclaved distilled water. The reaction mixtures were
incubated at 95°C for 5 min, followed by 40 amplification
cycles of 95°C for 10 s and 60°C (58°C for β-actin) for 10 s
and 72°C for 10 s. RT-PCR was performed using the ABIH. Liu et al.
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Prism 7700 sequence detector. The expression of Notch1
and Hes5 was normalized to β-actin levels. The primers
employed are shown as below: β-actin: 5'GAACCCTAA
GGCCAACCGTG3' and 5'AGGCATACAGGGACAACA
CAGC3'; Notch1: 5'GAGGCTTGAGATGCTCCCAG3' and
5'ATTCTTACATGGTGTGCTGAGG3'; Hes5: 5'-GCACCA
GCCCAACTCCAAAC-3' and 5'-TGCAGGCACCACGAG
TAGCC-3'.
Western blot
The protein expression levels of Notch1, Hes5 and β-actin
(loading control) were measured by western blot analysis
after 6 days in culture. Cells were washed with ice-cold PBS
and then lysed with radioimmunoprecipitation assay buffer.
The lysates was centrifuged at 12000 rpm for 10 min at 4°C
and the pellets were discarded. Protein concentrations in the
supernatants were determined with a BCA protein assay kit,
using bovine serum albumin as a standard. Equal amounts of
protein were loaded in each well for sodium dodecyl sulfate-
12% polyacrylamide gel electrophoresis and then the
separated proteins were transferred to nitrocellulose
membranes. The membranes were blocked in Tris-buffered
saline contained Blotto solution for 2 h at room temperature.
The membranes were then incubated with the primary
antibodies (rabbit anti-notch1 antibody, rabbit anti-hes5
antibody, 1:1000) and β-actin (1:5000) overnight at 4°C in
Tris-buffered saline containing 0.1% Tween 20 (TBS-T).
Membranes were rinsed 3 times with TBS-T before being
incubated with horseradish peroxidase-conjugated secondary
antibody (1:30000 in TBS-T) for 50 min and detected by
chemiluminescence. Quantitation of proteins was done by
densitometric analysis of using NIH Image software
(version 1.61).
Statistics
Numerical data are presented as mean ± standard devia-
tion (SD) values based on n number of experiments.
Differences between means were evaluated by one-way
ANOVA followed by Tukey’s multiple comparison test.
p<0.05 was considered statistically significant.
Results
The cells cultured from embryonic brain grew in spheroids
and expressed the NSC marker nestin (Fig. 1A). BrdU is a
thymidine analog that is incorporated into cells during the S
phase of the cell cycle in proliferating cells. In our study,
many of the cells in neurospheres also incorporated BrdU, as
indicated by the green staining of nuclei (Fig. 1B). Double
immunofluorescence staining of cells showed colocalization
of nestin-positive and BrdU-positive cells (Fig. 1C). Nestin/
BrdU double-labeled cells are NSCs which possessed the
abilities of proliferation.
Supplementation for 6 days with 40 mg/l folic acid
(Folate-H treatment) increased the percentages of cells in
the neurospheres that were nestin/BrdU double-positive
(Fig. 2A). This observation indicates that the additional folic
acid increased rapidly the relative abundance of proliferating
NSCs.
The effect of folic acid supplementation on the growth of
neurosphere cultures was also quantitated using the MTT
assay of viable cells. As shown in Fig. 2B, the abundance of
viable cells depended on time and folic acid concentration.
After 5–7 days in culture, there were significantly more
viable cells in cultures that were supplemented with folic
acid than in those that were not (Fig. 2B). This effect was
concentration-dependent because, after treatment periods of
5 days or longer, the Folate-H cultures contained more
viable cells than did the Folate-L cultures (Fig. 2B).
Fig. 1. Embryonic neurospheres contain proliferating neural stem cells (NSCs). The neurospheres were grown under control conditions
in serum-free medium containing 4 mg/l folic acid. On the sixth day in culture, the neurospheres were incubated with the
proliferation marker 5'bromo-2'deoxyuridine (BrdU) for 24 h. Subsequently they were stained with specific primary antibodies
and fluorescent secondary antibodies to detect BrdU and the NSC marker nestin. Shown are fluorescence photomicrographs of
cells expressing nestin (red fluorescence, A), BrdU (green, B), and both nestin and BrdU (yellow, C). The original magnifica-
tion for fluorescence microscopy was ×200.Folic Acid and Neural Stem Cell Proliferation
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Nevertheless, the Folate-L treatment did eventually stimulate
proliferation above the Control level (Fig. 2B).
The Folate-H treatment, but not the Folate-L treatment,
increased the expression of Notch1 mRNA (Fig. 3A) and
protein (Fig. 4A). Both Folate-H and Folate-L stimulated
Hes5 expression at the mRNA (Fig. 3B) and protein
(Fig. 4B) levels. Further, the size of the effect on Hes5
mRNA expression was greater for the Folate-H treatment
than for the Folate-L treatment (Fig. 3B).
Discussion
The present study found that folic acid supplementation
exerts proliferative actions on embryonic NSCs. Analysis of
the underlying mechanism revealed that this effect of folic
acid is associated with increased mRNA and protein
expression of Notch1 and Hes5. Because NSCs are sources
of newly generated neurons and glia in the brain, our
findings suggest that folic acid may regulate neurogenesis
Fig. 2. Folic acid supplementation stimulates proliferation of embryonic neural stem cells (NSCs). A: Percentage of cells that were
double-positive for nestin and 5'bromo-2'deoxyuridine (BrdU), as determined by immunofluorescence analysis. B: Cell
proliferation quantified by measuring the time-dependent increase in the abundance of viable cells, which were identified by
methyl thiazolyl tetrazolium (MTT) assay. NSC neurospheres were incubated at 37°C, for the indicated periods, in medium
containing 4 mg/l folic acid (Control), 8 mg/l folic acid (Folate-L), or 44 mg/l folic acid (Folate-H). MTT was added to each
well at 4 h before the end of the incubation. Finally the resulting precipitates were dissolved in dimethyl sulphoxide and optical
density (OD) was measured at 490 nm. Shown are mean ± SD values of 8 separate experiments. One-way analysis of variance
and Tukey’s multiple comparison were performed to compare the mean values. ap<0.05 vs Control, bp<0.05 vs Folate-L.
Fig. 3. Folic acid supplementation increases expression of Notch1 and Hes5 mRNAs. Neural stem cell (NSC) neurospheres were
incubated for 6 days in medium containing 4 mg/l folic acid (Control), 8 mg/l folic acid (Folate-L), or 44 mg/l folic acid
(Folate-H). Subsequently Notch1 and Hes5 mRNA levels were determined by real-time PCR and normalized to β-actin
expression. Shown are mean ± SD values of 3 experiments. ap<0.05 vs Control, bp<0.05 vs Folate-L.H. Liu et al.
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and gliogenesis by stimulating the Notch1 signaling pathway
in embryonic NSCs.
NSCs proliferate and maintain an undifferentiated state
when incubated with basic fibroblast growth factor. We found
that folic acid supplementation increased the percentage of
nestin/BrdU double-positive cells in embryonic neurospheres
grown in the presence of basic fibroblast growth factor. It
can be inferred that the number of proliferative NSCs was
enhanced by folic acid. Taken together, the present results
indicate that folic acid stimulates the proliferation of
embryonic NSCs.
There is abundant evidence that folate influences mitosis.
For example, experiments with mice have shown that,
compared to a normal maternal diet (2 mg folic acid/kg
diet), a maternal diet that is folate-deficient (0.0 mg folic
acid/kg diet) during E11–E17 decreases NSC proliferation
and increases apoptosis in the E17 brain [15]. There are
several ways in which folic acid supplementation may
influence cell proliferation [9]. Mammalian cells cannot
synthesize folate de novo, but they require folate for many
metabolic functions, including the conversion of serine to
glycine, the catabolism of histidine, the synthesis of
thymidylate, methionine, and purine, and the DNA methyla-
tion that regulates gene expression [16].
Folic acid supplementation modulates intracellular
signaling pathways that regulate mitosis and apoptosis [9].
Previously we observed that folic acid supplementation
increased mRNA expression of Notch signaling molecules
in neurosphere cultures of NSCs derived from neonatal rats,
but proteins expression hadn’t been detected [17]. In present
study, we further detected protein expression evolved in
Notch signaling pathway of embryonic NSCs. The Notch
signaling pathway is necessary for cell-cell communication,
which involves gene regulation mechanisms that control
multiple cell differentiation processes during embryonic and
adult life. The Notch gene is known to suppress apoptosis
and promote cell proliferation through a growth factor-
mediated survival pathway. Notch proteins act as receptors
in an evolutionarily conserved signaling pathway that
regulates cell proliferation and differentiation. In our study,
it is likely that folic acid stimulated the transcription and
translation of Notch1, because folic acid supplementation
increased Notch1 mRNA and protein levels in NSC neuro-
spheres. Hes genes are the conserved targets of Notch
signaling for regulating the expansion and differentiation
of neural progenitors. Hes5 as a known Notch effectors,
regulate the maintenance of neural stem cells and the
development of the central nervous system. Previously it has
been shown that Hes5 expression responds to Notch1; for
example, Hes5 mRNA expression is decreased in the CNS
of Notch1 deficient (Notch1–/–) mice [13]. Therefore, in the
present study, elevation of Hes5 mRNA and protein levels
in folic acid-supplemented NSCs may have been due to
stimulation by Notch1 of Hes5 transcription and translation.
Fig. 4. Folic acid supplementation increases expression of Notch1 and hairy and enhancer of split 5 (Hes5) proteins. Neural stem
cell (NSC) neurospheres were incubated for 6 days in medium containing 4 mg/l folic acid (Control), 8 mg/l folic acid
(Folate-L), or 44 mg/l folic acid (Folate-H). Subsequently Notch1 and Hes5 protein levels were determined by western blot
analysis and normalized to β-actin expression. A: Representative western blots of Notch1, Hes5 and β-actin. B: Notch1: β-actin
ratios. Shown are mean ± SD values of 3 experiments. ap<0.05 vs Control. C: Hes5: β-actin ratios. Shown are mean ± SD values
of 3 experiments. ap<0.05 vs Control.Folic Acid and Neural Stem Cell Proliferation
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Experiments with mouse mutants have found that genetic
disruptions of Notch signaling generally result in an increase
in neuronal differentiation markers and a decrease in NSC
markers, showing that Notch signaling maintains the NSC
phenotype [18]. Further, conditional deletion of Notch1 in
the telencephalon leads to decreased neuronal cell abundance
in vivo and decreased neurosphere formation in vitro, most
likely resulting from precocious neuronal differentiation and
earlier progenitor pool depletion [19]. Other studies also
found that deletion of Notch1 or Hes5 decreases neuro-
sphere formation in suspension cultures of NSCs [20, 21].
Conversely, activation of the Notch signaling pathway
inhibits differentiation of NSCs into terminal cell pheno-
types [22, 23]. Thus, Notch signaling maintains the NSC
pool. Hes5 is key effector in Notch signaling because this
transcriptional repressor is highly expressed by NSCs and
inhibits their neuronal differentiation [14, 24]. Therefore,
Hes5 upregulation may maintain the capacity for self-
renewal that we observed in embryonic NSCs after folic
acid supplementation.
In conclusion, this study has demonstrated that embryonic
NSCs respond to folic acid supplementation with increased
Notch signaling and cell proliferation. These results support
the hypothesis that folic acid supplementation promotes
proliferation of embryonic NSCs by activating Notch
signaling.
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